Search Results - Martin Cranage

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

    Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis? by Alberto Beretta, Martin Cranage, Donato Zipeto

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1

    Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1 by Susanne Bell, Martin Cranage, L. K. Borysiewicz, Tony Minson

    Published 1990
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

    Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides by Carolina Herrera, Martin Cranage, Ian McGowan, Peter A. Anton, Robin J. Shattock

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence

    Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence by Adrian M. Whatmore, Nicola Cook, G.A. Hall, S. Sharpe, Erling W. Rud, Martin Cranage

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

    Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant... by Leszek K. Borysiewicz, Julian Hickling, Shek Graham, John Sinclair, Martin Cranage, Geoffrey L. Smith, J. G. P. Sissons

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H

    Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus... by Martin Cranage, Geoffrey L. Smith, Susanne Bell, Harvi F. Hart, C. Hendricks Brown, Alan T. Bankier, Peter Tomlinson, B. G. Barrell, Tony Minson

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants

    Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants by Erling W. Rud, Martin Cranage, Jeannine M. Yon, J. Quirk, Lesley A. Ogilvie, Nicola Cook, S. Webster, Michael J. Dennis, B. E. Clarke

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Macaques Infected with Live Attenuated SIVmac Are Protected against Superinfection via the Rectal Mucosa

    Macaques Infected with Live Attenuated SIVmac Are Protected against Superinfection via the Rectal Mucosa by Martin Cranage, Adrian M. Whatmore, S. Sharpe, Nicola Cook, Natasha Polyanskaya, Sharon Leech, Jon Smith, Erling W. Rud, Michael J. Dennis, G.A. Hall

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

    Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. by Martin Cranage, Tony Kouzarides, Alan T. Bankier, Sandra C. Satchwell, Kathleen Weston, Peter Tomlinson, B. G. Barrell, Harvi F. Hart, Susanne Bell, A. C. Minson

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

    Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques by Awen Gallimore, Martin Cranage, Nicola Cook, Neil Almond, Janet S. Bootman, Erling Ruo, P. Silvera, Michael J. Dennis, T. Corcoran, Jim Stott, Andrew McMichael, Frances Gotch

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen

    Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Va... by Tomáš Hanke, Rachel V. Samuel, Tom Blanchard, Veronica Neumann, Todd M. Allen, Jon E. Boyson, Sally Sharpe, Nicola Cook, Geoffrey L. Smith, David I. Watkins, Martin Cranage, Andrew J. McMichael

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

    Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques by Thomas Lehner, Yufei Wang, Martin Cranage, Lesley A. Bergmeier, Elaine Mitchell, Louisa Tao, Graham Hall, Mike Dennis, Nicola Cook, Roger H. Brookes, Linda Klavinskis, Ian M. Jones, Carl Doyle, Robert Ward

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally

    Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally by D. J. Lewis, Carol Fraser, Abdel N. Mahmoud, Rebecca Wiggins, Maria Woodrow, Alethea Cope, Chun Cai, Rafaela Giemza, S. A. Jeffs, Maria Manoussaka, Tom Cole, Martin Cranage, Robin J. Shattock, Charles Lacey

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIV<sub>mac251</sub>: Dependence on Route of Challenge Exposure

    Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIV<sub>mac251</sub>: Dependence on Route of Challenge Exposure by John M. Benson, Claire Chougnet, Marjorie Robert-Guroff, David C. Montefiori, P D Markham, G M Shearer, Robert C. Gallo, Martin Cranage, Enzo Paoletti, Keith Limbach, David Venzon, James Tartaglia, Genoveffa Franchini

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel

    Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel by Martin Cranage, Sally Sharpe, Carolina Herrera, Alethea Cope, Mike Dennis, Neil Berry, Claire Ham, Jonathan L. Heeney, Naser L. Rezk, Angela D. M. Kashuba, Peter A. Anton, Ian McGowan, Robin J. Shattock

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: